The findings reported in animal models were also supported by human genetic studies which showed that PNPLA3 rs2294918 E434K variant decreased PNPLA3 expression, reducing the effect of the I148M variant on the predisposition to steatosis and liver damage (127). Here, PNPLA3 is linked to steatosis.